Figure 1.

The scheme of analysis and prediction of indexes of COVID-19 and myocarditis

The blood samples were collected from a diverse group of individuals, including 5,230 patients diagnosed with COVID-19 (4500 BA.5.2 & 730 EG.5), 562 individuals suffering from myocarditis, and approximately 4,012 healthy individuals. These samples were then analyzed to identify various biochemical indicators and biomarkers. The data derived from this analysis was subsequently input into a statistical model. This model was designed to systematically predict both the diagnosis and prognosis of myocarditis, providing a potentially powerful tool in the fight against this condition.